JDRF Blog

Latest in Clinical trials

  • Can Prozac Prevent Severe Low Blood Sugar?

    January 13, 2020

    Low blood sugar, called hypoglycemia, occurs in over 90 percent of people with type 1 diabetes (T1D). It can usually be detected...

  • The Promising Clinical Trials in the JDRF Pipeline

    December 9, 2019

    As the leading global funder of type 1 diabetes (T1D) research, JDRF invests in the most promising research studies across the world—including...

  • One Less Device: Combining CGM and Insulin Infusion—JDRF Clinical Trial

    December 9, 2019

    JDRF is funding work to build a better insulin infusion set; the current infusion sets can be uncomfortable and unreliable, and need...

  • Why Does One Scientist Seek Cures for T1D? Answer: Family

    December 3, 2019

    Reza Abdi, M.D., has a reason to care about diabetes research—he has a father and a brother with the disease. Dr. Abdi,...

  • Production of Insulin in People with Type 1 Diabetes

    November 25, 2019

    Sernova, a clinical-stage regenerative medicine company, has shown in its JDRF-funded clinical trial that its cell replacement therapy, the Cell Pouch System™,...

  • This Stent is a Champion for Type 1 Diabetes Clinical Trials

    November 7, 2019

    Stent—Maribeth Stent—was diagnosed with type 1 diabetes (T1D) in the fall of 1997. “It was right around my second birthday,” said Maribeth....

  • Can Two Viral Drugs Halt Type 1 Diabetes?

    October 17, 2019

    Scientists in Norway are seeking participants for a clinical trial to see if a course of anti-viral treatment may stop beta cell...

  • JDRF Innovative Clinical Trial Design Workshop

    August 27, 2019

    BMC Medicine 16: 29 (2018)

  • Advancing the Cure with Type 1 Diabetes Clinical Trials

    May 20, 2019

     JDRF funds type 1 diabetes (T1D) clinical trials that are critical to bringing new devices and treatments to people with this disease....

  • In First-In-Human Tests, New Artificial Pancreas System Smartphone App Shows Reliable Glucose Control

    February 25, 2019

    Artificial pancreas (AP) systems “close the loop” between continuous glucose monitors and insulin pumps, using a computer algorithm to calculate and administer...